Overview of the NDA/BLA Process in South Korea

The webinar was successfully concluded on

November 29, 2023

Topics Covered:

Introduction
Types of Business Licenses for Drug Products in Korea
Dossier Preparation
MFDS Review Process
Health Authority Meeting
GMP Site Inspection
Approval
DMF Registration
Orphan Drug Designation
Question & Answers

As a continuous practice, Freyr will continue to organize more webinar sessions related to Regulatory aspects in Life Sciences. We presume you would like to be a part of all those sessions. If yes, we will be happy to inform you in prior about the next session.

Michael has forty (40) years of industry experience, with twenty-nine (29) years in CMC Regulatory functions and an additional eleven (11) years in other scientific development roles. His experience includes collaborating with Regulatory partner companies.

In Pyo Hong is a Regulatory Expert with over twenty-five (25) years of experience in the Korean pharmaceutical industry. He specializes in Regulatory affairs for pharmaceutical and healthcare products.

Hosted By

Michael Lambell

Sr. Vice President, MPR Regulatory Affairs

Presented By

In Pyo Hong

Associate Director, MPR Regulatory Affairs – South Korea

Creating compliant packaging for a cosmetic product is a collaborative effort of various departments in an organization such as: Labeling, Artwork and Regulatory Affairs. While label artwork must be validated by an artwork labeling team, it must combinedly be reviewed and approved by Regulatory Affairs team to ensure the compliance.

Artwork services for the current Consumer Healthcare/Food Supplements landscapes are divided as per the markets. For Compliance based markets, artworks are created by Freyr team and submitted to the client for finalizing the artwork/ label.

The current medical device landscape has turned challenging for manufacturers in terms of ensuring quality and audit compliance due to ever-evolving regulations which may lead to extended time for approvals and market access.